Sima Porten

10PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 02, 2026
Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

|Mar 17, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky

|Mar 12, 2026
Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer.

Corleone S Delaveris, Rita P Loudermilk, Apurva Pandey

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Mar 30, 2024
Association of household net worth with healthcare costs after radical cystectomy using real-world data.

Samuel L Washington, Peter E Lonergan, Anobel Y Odisho

|Sep 02, 2020
Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.

Samuel L Washington, Steven E Gregorich, Maxwell V Meng

Pageof 2

Frequent Collaborators

3 joint publications

Samuel L Washington

3 joint publications

Anobel Y Odisho

3 joint publications

Carissa E Chu

2 joint publications

Ahmed Eraky